COP
47
8
KMB
37
-7
MRK
50
13
NWSA
91
-6
NRG
82
2
PH
85
7
EQIX
68
-7
SYK
60
5
ADI
71
8
MLM
56
3
NTAP
65
10
FIS
67
2
PNR
80
9
OXY
56
6
AVB
60
5
DVA
65
2
ZION
75
10
DG
23
-4
CHRW
71
14
CMA
65
7
COP
47
8
KMB
37
-7
MRK
50
13
NWSA
91
-6
NRG
82
2
PH
85
7
EQIX
68
-7
SYK
60
5
ADI
71
8
MLM
56
3
NTAP
65
10
FIS
67
2
PNR
80
9
OXY
56
6
AVB
60
5
DVA
65
2
ZION
75
10
DG
23
-4
CHRW
71
14
CMA
65
7
Financhill
Back

BioNTech SE Stock Predictions

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
43

BNTX
BioNTech SE

Last Price:
$94.58
Seasonality Move:
39.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

BioNTech SE Stock Forecast

  • Over the next 52 weeks, BioNTech SE has on average historically risen by 44.8% based on the past 5 years of stock performance.
  • BioNTech SE has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
  • Is BioNTech SE Stock Undervalued?
    The current BioNTech SE [BNTX] share price is $97.27. The Score for BNTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BNTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BioNTech SE Stock Go Up Next Year?

  • Over the next 52 weeks, BioNTech SE has on average historically risen by 44.8% based on the past 5 years of stock performance.

BioNTech SE Stock Rating

Sell
43
BioNTech SE (BNTX) is a Sell

Is BioNTech SE overpriced?

  • BioNTech SE has risen higher in 1 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

BioNTech SE Stock Price History

Is BNTX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BNTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Germany
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biontech.de

52-Week Data

52-Week High:
131.49
52-Week Low:
76.53

Prediction Charts

Market Cap:
23.4B
Price in USD:
97.27
Volume:
818.2K
Beta:
0.38

Technical Analysis

SMA50:
99.72
SMA100:
108.42
SMA200:
106.32
52-Wk Change:
6.11%

Stock Predictions

  • Is BioNTech SE stock public?
    Yes, BioNTech SE is a publicly traded company.
  • What is the BioNTech SE stock quote today?
    The BioNTech SE stock price is 97.27 USD today.
  • How to buy BioNTech SE stock online?
    You can buy BioNTech SE shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-23 111.40 114.83 120.32 111.26
Apr-24 113.87 120.54 120.62 113.77
Apr-25 118.73 102.02 118.73 93.17
Apr-28 107.64 104.00 108.79 103.50
Apr-29 103.72 104.00 107.47 103.45
Apr-30 105.23 104.15 105.23 102.11
May-1 103.17 102.43 103.71 99.85
May-2 104.20 104.94 106.50 103.51
May-5 104.58 101.10 106.99 100.28
May-6 100.81 94.74 100.81 92.40
May-7 96.52 92.80 97.05 92.61
May-8 94.58 94.78 95.66 92.26
May-9 95.23 92.77 96.30 92.75
May-12 94.02 97.27 97.49 93.94

BioNTech SE Earnings

BioNTech SE Earnings Report: Per Share BioNTech SE Earnings Q1 Q2 Q3 and Q4 last year and next year.

BioNTech SE Forecast Revenue Growth

BioNTech SE Stock Analysis: Historical quarterly revenues per share for BioNTech SE and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.87 per share, a decrease next quarter of $2.12 per share, a decrease this year of $2.41 per share, and an increase next year of $0.14 per share.

* BioNTech SE stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.